Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports

BACKGROUND: Non-Hodgkin lymphomas are a heterogeneous group, which involve either B or T lymphocytes. The most used treatment is a chemotherapy regimen, which includes cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone combined with rituximab - a monoclonal antibody specific for CD20 - an...

Descripción completa

Detalles Bibliográficos
Autores principales: Campione, Elena, Di Prete, Monia, Del Principe, Ilaria, Diluvio, Laura, Citarella, Luigi, Orlandi, Augusto, Chimenti, Sergio, Bianchi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788900/
https://www.ncbi.nlm.nih.gov/pubmed/26968156
http://dx.doi.org/10.1186/s13256-016-0834-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788900/
https://www.ncbi.nlm.nih.gov/pubmed/26968156
http://dx.doi.org/10.1186/s13256-016-0834-6

Ejemplares similares